Hematopoietic Stem Cell Transplantation
Medicine & Life Sciences
100%
Allogeneic Cells
Medicine & Life Sciences
24%
Stem Cell Transplantation
Medicine & Life Sciences
21%
Human Herpesvirus 6
Medicine & Life Sciences
18%
Graft vs Host Disease
Medicine & Life Sciences
15%
Whole-Body Irradiation
Medicine & Life Sciences
15%
Aplastic Anaemia
Medicine & Life Sciences
13%
Cytomegalovirus
Medicine & Life Sciences
13%
Ikeda, K. ,
Minakawa, K. ,
Yamahara, K. ,
Yamada-Fujiwara, M. ,
Okuyama, Y. ,
Fujiwara, S. I. ,
Yamazaki, R. ,
Kanamori, H. ,
Iseki, T. ,
Nagamura-Inoue, T. ,
Kameda, K. ,
Nagai, K. ,
Fujii, N. ,
Ashida, T. ,
Hirose, A. ,
Takahashi, T. ,
Ohto, H. ,
Ueda, K. &
Tanosaki, R. ,
2022 6月 ,
In: Transfusion. 62 ,
6 ,
p. 1280-1288 9 p. 研究成果: Article › 査読
Dimethyl Sulfoxide
100%
Peripheral Blood Stem Cells
45%
Starch
40%
Peripheral Blood Stem Cell Transplantation
23%
Respect
19%
Sakurai, M. ,
Nannya, Y. ,
Yamazaki, R. ,
Yamaguchi, K. ,
Koda, Y. ,
Abe, R. ,
Yokoyama, K. ,
Ogawa, S. &
Mori, T. ,
2022 1月 ,
In: Annals of Hematology. 101 ,
1 ,
p. 237-239 3 p. 研究成果: Letter › 査読
Yokoyama, Y. ,
Nozawa, E. ,
Morita, M. ,
Ishikawa, E. ,
Mori, T. ,
Sakurai, M. ,
Kikuchi, T. ,
Matsuki, E. ,
Yamazaki, R. ,
Kataoka, K. ,
Jibiki, A. ,
Kawazoe, H. ,
Suzuki, S. &
Nakamura, T. ,
2022 8月 ,
In: Journal of Clinical Laboratory Analysis. 36 ,
8 , e24598.
研究成果: Article › 査読
Ponatinib
100%
Bosutinib
97%
Nilotinib
90%
bosutinib
86%
ponatinib
85%
Ochiai, D. ,
Abe, Y. ,
Yamazaki, R. ,
Uemura, T. ,
Toriumi, A. ,
Matsuhashi, H. ,
Tanaka, Y. ,
Ikenoue, S. ,
Kasuga, Y. ,
Tanosaki, R. &
Tanaka, M. ,
2021 9月 ,
In: Medicina (Lithuania). 57 ,
9 , 983.
研究成果: Article › 査読
Postpartum Hemorrhage
100%
Blood Transfusion
73%
Japan
64%
University Hospitals
61%
Retrospective Studies
52%
Mori, T. ,
Kikuchi, T. ,
Koh, M. ,
Koda, Y. ,
Yamazaki, R. ,
Sakurai, M. ,
Tomita, Y. ,
Ozawa, Y. ,
Kohashi, S. ,
Abe, R. ,
Saburi, M. &
Kato, J. ,
2021 6月 ,
In: Bone Marrow Transplantation. 56 ,
6 ,
p. 1266-1271 6 p. 研究成果: Article › 査読
Cytomegalovirus Retinitis
100%
Hematopoietic Stem Cell Transplantation
74%
Cytomegalovirus
69%
Cytomegalovirus Infections
43%
Incidence
24%